Anupam Dalal - 26 Aug 2021 Form 4/A - Amendment Insider Report for Aadi Bioscience, Inc. (WHWK)

Role
Director
Signature
/s/ Neil Desai, as Attorney-in-Fact
Issuer symbol
WHWK
Transactions as of
26 Aug 2021
Net transactions value
+$19,999,990
Form type
4/A - Amendment
Filing time
31 Aug 2021, 19:52:56 UTC
Date Of Original Report
30 Aug 2021
Previous filing
02 Jul 2021
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AADI Common Stock Purchase $19,999,990 +1,529,402 $13.08 1,529,402 26 Aug 2021 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of (i) 1,284,698 shares held by Acuta Capital Fund, LP ("Acuta Capital") and (ii) 244,704 shares held by Acuta Opportunity Fund, LP. ("Acuta Opportunity Fund"). Acuta Capital Partners, LLC ("Acuta Partners") is the general partner of each of Acuta Capital and Acuta Opportunity Fund. The Reporting Person is the Chief Investment Officer and Managing Member of Acuta Partners. The Reporting Person has voting and investment authority over all of the shares held by each of Acuta Capital and Acuta Opportunity Fund. Each of Acuta Partners and the Reporting Person disclaim beneficial ownership of the shares of common stock held by each of Acuta Capital and Acuta Opportunity Fund except to the extent of their pecuniary interest therein.
F2 This amendment is filed to correct footnote (1) included in the Form 4 filed August 30, 2021.